Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin  Shirley Uitte de Willige, Joyce J.M.C. Malfliet, Jaap W. Deckers, Diederik W.J. Dippel, Frank W.G. Leebeek, Dingeman C. Rijken  International Journal of Cardiology  Volume 178, Pages 105-110 (January 2015) DOI: 10.1016/j.ijcard.2014.10.091 Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 A) Mean sFAP level (log scale)±sd per time in months between event and study inclusion in CHD patients (n=370). B) Mean percentage α2AP N-terminal cleavage±sd and time in months between event and study inclusion in CHD patients (n=222). International Journal of Cardiology 2015 178, 105-110DOI: (10.1016/j.ijcard.2014.10.091) Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions

Fig. 2 Correlation between sFAP level and a2AP N-terminal cleavage. A) Control population (n=298). B) Patient subgroups; CHD patients (n=222): open circles and dashed line, IS patients (n=125): closed squares and dotted line, PAD patients (n=31): gray diamonds and dash-dot-dash line. sFAP level is shown on a log scale. International Journal of Cardiology 2015 178, 105-110DOI: (10.1016/j.ijcard.2014.10.091) Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions